ArticleScientific reports2026
Exploring the limits of pre-trained embeddings in machine-guided protein design: a case study on predicting AAV vector viability.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Effective representations of protein sequences are widely recognized as a cornerstone of machine learning-based protein design. Yet, protein bioengineering poses unique challenges for sequence representation, as experimental datasets typically feature few mutations, which are either sparsely distributed across the entire sequence or densely concentrated within localized regions. This limits the ability of sequence-level representations to extract functionally meaningful signals. In addition, comprehensive comparative studies remain scarce, despite their crucial role in clarifying which representations best encode relevant information and ultimately support superior predictive performance. In this study, we systematically evaluate multiple ProtBERT and ESM2 embedding variants as sequence representations, using the adeno-associated virus capsid as a case study and prototypical example of bioengineering, where functional optimization is targeted through highly localized sequence variation within an otherwise large protein. Our results reveal that, prior to fine-tuning, amino acid–level embeddings outperform sequence-level representations in supervised predictive tasks, whereas global sequence-level embeddings tend to be more effective in unsupervised settings. However, optimal performance is only achieved when embeddings are fine-tuned with task-specific labels, with sequence-level representations providing the best performances. Moreover, our findings indicate that the extent of sequence variation required to produce notable shifts in sequence representations exceeds what is typically explored in bioengineering studies, showing the need for fine-tuning in datasets characterized by sparse or highly localized mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.